Swedish (OMX) Pharmaceuticals & Biotech Aandelen - Grootste verliezers vandaag

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 29, 2026

Ontdek de Swedish (OMX) Grootste verliezers van vandaag. Deze Pharmaceuticals & Biotech Stocks hebben de grootste daling in Market Cap gezien ten opzichte van de vorige handelsdag.

92 bedrijven

Bedrijf	Laatste prijs	1D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
MCAP	SEK 510.00	-3.8%	17.1%	SEK 7.7b	SEK 617.50	34.0	14.9%	n/a
VITR	SEK 98.90	-2.0%	-36.3%	SEK 13.4b	SEK 162.75	3.9	103.5%	1.1%
CANTA	SEK 2.18	-25.3%	57.3%	SEK 542.0m	SEK 10.00	3.4	-54.8%	n/a
BONEX	SEK 229.80	-0.8%	-9.6%	SEK 15.1b	SEK 373.83	81.8	33.8%	n/a
VICO	SEK 11.70	-3.3%	42.2%	SEK 3.3b	SEK 29.50	933.9	-12.4%	n/a
CRNO B	SEK 5.35	-3.3%	-47.8%	SEK 1.7b	SEK 20.00	25.0	-28.9%	n/a
ONCO	SEK 1.81	-6.6%	9.2%	SEK 715.5m	SEK 2.60	8.6	87.0%	n/a
BINV	SEK 33.10	-1.9%	-6.8%	SEK 2.2b	SEK 95.00	10.0	42.2%	n/a
ORX	SEK 20.50	-3.3%	41.2%	SEK 715.9m	SEK 29.00	40.2	16.5%	n/a
SUBGEN	SEK 0.13	-17.5%	n/a	SEK 129.3m	n/a	0.3	n/a	n/a
DICOT	SEK 0.20	-5.3%	-65.5%	SEK 393.8m	n/a	6.7	n/a	n/a
FLERIE	SEK 23.30	-0.9%	-39.8%	SEK 2.2b	SEK 39.38	1231.1	n/a	n/a
SANION	SEK 15.22	-0.8%	86.1%	SEK 2.1b	SEK 20.00	9.6	-14.4%	n/a
NICA	SEK 0.64	-7.5%	-41.7%	SEK 211.7m	SEK 1.70	8.8	50.7%	n/a
SPRINT	SEK 3.47	-4.1%	694.1%	SEK 366.1m	SEK 4.80	4.3	3.6%	n/a
ACE	SEK 3.09	-3.4%	-25.2%	SEK 412.6m	SEK 5.60	5.0	104.9%	n/a
XBRANE	SEK 10.45	-6.3%	-62.8%	SEK 215.3m	SEK 15.00	2.8	34.3%	n/a
MOB	SEK 10.20	-2.3%	9.0%	SEK 479.4m	SEK 14.00	32.9	100.9%	n/a
XINT	SEK 0.23	-5.4%	-40.6%	SEK 196.4m	n/a	86.1	n/a	n/a
ODI	SEK 3.34	-16.5%	65.3%	SEK 61.2m	n/a	2.0	n/a	n/a
ACTI	SEK 0.063	-4.8%	-81.4%	SEK 165.5m	n/a	3.0	90.7%	n/a
VIVE	SEK 10.74	-5.8%	-53.3%	SEK 118.9m	SEK 24.00	1.0	-23.4%	n/a
GEAN	NOK 0.88	-11.1%	31.3%	NOK 60.8m	n/a	3.1	n/a	n/a
DEX	SEK 7.15	-4.7%	68.6%	SEK 132.2m	n/a	31.2	n/a	n/a

Page 1 of 4